Evidence map›Paper›PMID 22493092›Full record

ArticleJournal of lipid research2012

The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid.

Jingjing Liu, Shuang Liang, Xiaoxi Liu, J Andrew Brown, Kylie E Newman, Manjula Sunkara, Andrew J Morris, Saloni Bhatnagar, Xiangan Li, Aurora Pujol and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Peroxisome Dysfunction and Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Peroxisomal ABC Transporters: An Update.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. ABCD2 identifies a subclass of peroxisomes in mouse adipose tissue.Biochemical and biophysical research communications · 2015
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jingjing LiuDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA.
Shuang Liang
Xiaoxi Liu
J Andrew Brown
Kylie E Newman
Manjula Sunkara
Andrew J Morris
Saloni Bhatnagar
Xiangan Li
Aurora Pujol
Gregory A Graf
University of Kentucky · USCentre for Biomedical Network Research on Rare Diseases · ES

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2012 to 2017
$13.7M
THROMBOSPONDIN1 MEDIATES MACROPHAGE INFILTRATION INTO ADIPOSE TISSUE AND PROMOTEP20RR021954 · NCRR · UNIVERSITY OF KENTUCKY · PI ECKHARDT, ERIK · 2008 to 2011
$8.3M
Role of Lipid Phosphatases in Cholesterol and Triglyceride SynthesisR01GM050388 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI MORRIS, ANDREW J · 1994 to 2011
$2.7M
Regulation of the ABCG5 ABCG8 Sterol TransporterR01DK080874 · NIDDK · UNIVERSITY OF KENTUCKY · PI GRAF, GREGORY A · 2009 to 2012
$1.3M
Protective Effects of Stearic Acid on Gestational and Acquired Diabetes MellitusR01DK077632 · NIDDK · UNIVERSITY OF KENTUCKY · PI GRAF, GREGORY A, SMART, ERIC J · 2006 to 2009
$1.2M
Thermo/Finnigan TSQ AM Triple Stage Quadrupole Mass SpectrometerS10RR024598 · NCRR · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2008 to 2008
$493k
NCRR NIH HHS 5P20RR021954-05NCRR NIH HHS P20 RR021954NCRR NIH HHS S10 RR024598NIDDK NIH HHS R01 DK077632NIDDK NIH HHS R01DK077632NIDDK NIH HHS R01 DK080874NIDDK NIH HHS R01DK080874NIGMS NIH HHS 8 P20 GM103527-05NIGMS NIH HHS P20 GM103527NIGMS NIH HHS R01 GM050388NIGMS NIH HHS R01GM50388-19
6 · The paper itself

Abstract

ABCD2 (D2) is a peroxisomal transporter that is highly abundant in adipose tissue and promotes the oxidation of long-chain MUFA. Erucic acid (EA, 22:1ω9) reduces very long chain saturated fatty acids in patients with X-linked adrenoleukodystrophy but promotes dyslipidemia and dilated cardiomyopathy in rats. To determine the role of D2 in the metabolism of EA, we challenged wild-type and D2 deficient mice (D2 KO) with an enriched EA diet. In D2 KO mice, dietary EA resulted in the rapid expansion of adipose tissue, adipocyte hypertrophy, hepatic steatosis, and the loss of glycemic control. However, D2 had no impact on the development of obesity phenotypes in two models of diet-induced obesity. Although there was a significant increase in EA in liver of D2 KO mice, it constituted less than 2% of all fatty acids. Metabolites of EA (20:1, 18:1, and 16:1) were elevated, particularly 18:1, which accounted for 50% of all fatty acids. These data indicate that the failure to metabolize EA in adipose results in hepatic metabolism of EA, disruption of the fatty acid profile, and the development of obesity and reveal an essential role for D2 in the protection from dietary EA.

Indexed as

Adipose TissueAnimalsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily DBlood GlucoseDietary FatsDisease SusceptibilityDyslipidemiasErucic AcidsFatty LiverFemaleGene Expression RegulationInsulin ResistanceLipid MetabolismMiceMice, Inbred C57BLABCD2 protein, mouseATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily DBlood GlucoseDietary Fatserucic acidErucic Acids

Identifiers

PMID22493092
PMCPMC3351814
OpenAlexW2169198250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.